MDMA (Ecstasy) decreases the number of neurons and stem cells in embryonic cortical cultures

Cellular and Molecular Neurobiology

Volumn 30, Issue 1, 2010, Pages 13-21

  Kindlundh Högberg, Anna M S ^a   Pickering, Chris ^c   Wicher, Grzegorz ^a   Hobér, David ^a   Schiöth, Helgi B ^a   Fex Svenningsen, Åsa ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5HT3 receptor; Cell culture; Cell death; Cortex; Dopamine D1 receptor; Embryos; Glutamate transporter; MDMA; MRNA; Neural stem cell

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CASPASE 3; DOPAMINE 1 RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 2 1; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NESTIN; NEURON SPECIFIC NUCLEAR PROTEIN; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CASPASE 3; CELL COUNT; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEM CELLS;

RATTUS;

EID: 76749103795     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9426-y     Document Type: Article

References (51)

1. NM Barnes T Sharp 1999 A review of central 5-HT receptors and their function Neuropharmacology 38 1083 1152 10.1016/S0028-3908(99)00010-6 1:CAS:528:DyaK1MXltVCgsrg%3D 10462127 (Pubitemid 29292403)
2. UV Berger TM DeSilva W Chen PA Rosenberg 2005 Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization J Comp Neurol 492 78 89 10.1002/cne.20737 1:CAS:528:DC%2BD2MXhtFGiurrM 16175560 (Pubitemid 41369160)
3. WW Blessing B Seaman 2003 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats Neuroscience 117 939 948 10.1016/S0306-4522(02)00810-2 1:CAS:528: DC%2BD3sXit1Kmsr8%3D 12654345 (Pubitemid 36332311)
4. A Bortolozzi L Diaz-Mataix MC Scorza P Celada F Artigas 2005 The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity J Neurochem 95 1597 1607 10.1111/j.1471-4159.2005.03485.x 1:CAS:528: DC%2BD28XhsVKisA%3D%3D 16277612 (Pubitemid 41804057)
5. NG Campbell JB Koprich NM Kanaan JW Lipton 2006 MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment Neurotoxicol Teratol 28 459 465 10.1016/j.ntt.2006.05.006 1:CAS:528: DC%2BD28XpsVWltLo%3D 16905291 (Pubitemid 44332878)
6. JP Capela A Meisel AR Abreu PS Branco LM Ferreira AM Lobo F Remiao ML Bastos F Carvalho 2006 Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia J Pharmacol Exp Ther 316 53 61 10.1124/jpet.105.092577 1:CAS:528:DC%2BD28XhslektA%3D%3D 16183702 (Pubitemid 41832580)
7. JP Capela K Ruscher M Lautenschlager D Freyer U Dirnagl AR Gaio ML Bastos A Meisel F Carvalho 2006 Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia Neuroscience 139 1069 1081 10.1016/j.neuroscience.2006.01.007 1:CAS:528:DC%2BD28XktVygtr4%3D 16504407
8. JP Capela E Fernandes F Remiao ML Bastos A Meisel F Carvalho 2007 Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons Neurotoxicology 28 868 875 10.1016/j.neuro.2007.04.005 1:CAS:528: DC%2BD2sXotVWmsb0%3D 17572501 (Pubitemid 47064474)
9. E Carboni E Acquas P Leone G Di Chiara 1989 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward Psychopharmacology (Berl) 97 175 178 10.1007/BF00442245 1:CAS:528: DyaL1MXhsVOlt7s%3D (Pubitemid 19040157)
10. A Carlsson 2006 The neurochemical circuitry of schizophrenia Pharmacopsychiatry 39 Suppl 1 S10 S14 10.1055/s-2006-931483 1:CAS:528: DC%2BD28Xjt12nuro%3D 16508890 (Pubitemid 43357100)
11. KO Cho SK Kim GS Rhee SJ Kwack DH Cho KW Sung SY Kim 2007 Chronic 3, 4-methylenedioxymethamphetamine treatment suppresses cell proliferation in the adult mouse dentate gyrus Eur J Pharmacol 566 120 123 10.1016/j.ejphar.2007.04. 008 1:CAS:528:DC%2BD2sXlvFantLw%3D 17498687 (Pubitemid 46782814)
12. T Chu Y Kumagai EW DiStefano AK Cho 1996 Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion Biochem Pharmacol 51 789 796 10.1016/0006-2952(95)02397-6 1:CAS:528:DyaK28XhslKnurs%3D 8602874 (Pubitemid 26094447)
13. CA Crawford MT Williams JL Kohutek FY Choi ST Yoshida SA McDougall CV Vorhees 2006 Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats Brain Res 1077 178 186 10.1016/j.brainres. 2006.01.017 1:CAS:528:DC%2BD28XisF2mtLs%3D 16483555
14. HN David M Ansseau JH Abraini 2005 Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals Brain Res Brain Res Rev 50 336 360 1:CAS:528:DC%2BD2MXht1GisbbF 16278019
15. MJ Detke S Wieland I Lucki 1995 Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists Psychopharmacology (Berl) 119 47 54 10.1007/BF02246053 1:CAS:528:DyaK2MXmtFChtb8%3D
16. L Galineau C Belzung E Kodas S Bodard D Guilloteau S Chalon 2005 Prenatal 3, 4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat Brain Res Dev Brain Res 154 165 176 10.1016/j.devbrainres.2004.10.012 1:CAS:528: DC%2BD2MXhtFOntbc%3D 15707670 (Pubitemid 40221861)
17. CR Gardner 1988 Potential use of drugs modulating 5HT activity in the treatment of anxiety Gen Pharmacol 19 347 356 1:CAS:528:DyaL1cXktVSjtbs%3D 2901381
18. AR Green AO Mechan JM Elliott E O'Shea MI Colado 2003 The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Rev 55 463 508 10.1124/pr.55.3.3 1:CAS:528:DC%2BD3sXnsVynurs%3D 12869661 (Pubitemid 37013213)
19. GA Gudelsky JF Nash 1996 Carrier-mediated release of serotonin by 3, 4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions J Neurochem 66 243 249 1:CAS:528:DyaK2MXhtVSns7jE 8522960
20. M Heilig M Egli 2006 Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms Pharmacol Ther 111 855 876 10.1016/j.pharmthera.2006.02.001 1:CAS:528:DC%2BD28Xns1SksL8%3D 16545872 (Pubitemid 44118437)
21. V Hernandez-Rabaza L Dominguez-Escriba JA Barcia JF Rosel FJ Romero JM Garcia-Verdugo JJ Canales 2006 Binge administration of 3, 4- methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus Neuropharmacology 51 967 973 10.1016/j.neuropharm.2006.06.019 1:CAS:528:DC%2BD28XhtVyktLzF 16949621 (Pubitemid 44550123)
22. E Ho L Karimi-Tabesh G Koren 2001 Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine) Neurotoxicol Teratol 23 561 567 10.1016/S0892-0362(01)00178-7 1:CAS:528:DC%2BD38XktFCgtQ%3D%3D 11792525 (Pubitemid 34132930)
23. YJ Ho CR Pawlak L Guo RK Schwarting 2004 Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat Behav Brain Res 149 135 144 10.1016/S0166-4328(03)00220-1 1:CAS:528:DC%2BD2cXhtFWgt7g%3D 15129777 (Pubitemid 38199929)
24. PW Kalivas N Volkow J Seamans 2005 Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission Neuron 45 647 650 10.1016/j.neuron.2005.02.005 1:CAS:528:DC%2BD2MXis1yrs78%3D 15748840 (Pubitemid 40320699)
25. AE Kelley KC Berridge 2002 The neuroscience of natural rewards: relevance to addictive drugs J Neurosci 22 3306 3311 1:CAS:528:DC%2BD38Xjs1Shurk%3D 11978804
26. AMS Kindlundh-Högberg P Svenningsson HB Schioth 2006 Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain Neuropharmacology 51 838 847 10.1016/j.neuropharm.2006.05.026 16820177 (Pubitemid 44286936)
27. AMS Kindlundh-Högberg HB Schioth P Svenningsson 2007 Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain Neurotoxicology 28 1158 1169 10.1016/j.neuro.2007.07.002 17692920 (Pubitemid 350026594)
28. AMS Kindlundh-Högberg A Blomqvist R Malki HB Schioth 2008 Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats BMC Neurosci 9 39 10.1186/1471-2202-9-39 18419818 (Pubitemid 351619147)
29. S Koch MP Galloway 1997 MDMA induced dopamine release in vivo: role of endogenous serotonin J Neural Transm 104 135 146 10.1007/BF01273176 1:CAS:528:DyaK2sXktFaruro%3D 9203077
30. JB Koprich NG Campbell JW Lipton 2003 Neonatal 3, 4- methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat Brain Res Dev Brain Res 147 177 182 10.1016/S0165-3806(03)00219-0 1:CAS:528:DC%2BD2cXntV2hsQ%3D%3D 14741762 (Pubitemid 38114707)
31. JB Koprich EY Chen NM Kanaan NG Campbell JH Kordower JW Lipton 2003 Prenatal 3, 4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats Neurotoxicol Teratol 25 509 517 10.1016/S0892-0362(03)00091-6 1:CAS:528:DC%2BD3sXntVCnsrg%3D 12972064 (Pubitemid 37103049)
32. PR McElhatton DN Bateman C Evans KR Pughe SH Thomas 1999 Congenital anomalies after prenatal ecstasy exposure Lancet 354 1441 1442 10.1016/S0140-6736(99)02423-X 1:STN:280:DC%2BD3c%2FgvFSiug%3D%3D 10543673 (Pubitemid 29494758)
33. Mordenti J, Chappell W (1989) The use of interspecies scaling in toxicokinetics. In: Yacogi A, Kelley J, Batra V (eds) Toxicokinetics and new drug development. Pergamon Press, New York, pp 42-96
34. J Morton 2005 Ecstasy: pharmacology and neurotoxicity Curr Opin Pharmacol 5 79 86 10.1016/j.coph.2004.08.007 1:CAS:528:DC%2BD2MXms1Clsw%3D%3D 15661630 (Pubitemid 40124539)
35. DE Nichols 1986 Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens J Psychoactive Drugs 18 305 313 1:CAS:528:DyaL2sXhtlWjtL4%3D 2880944
36. SC Noctor V Martinez-Cerdeno L Ivic AR Kriegstein 2004 Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases Nat Neurosci 7 136 144 10.1038/nn1172 1:CAS:528:DC%2BD2cXmvVGmtg%3D%3D 14703572 (Pubitemid 38129789)
37. JG Parnavelas 2000 The origin and migration of cortical neurones: new vistas Trends Neurosci 23 126 131 10.1016/S0166-2236(00)01553-8 1:CAS:528:DC%2BD3cXhsFOisLk%3D 10675917 (Pubitemid 30110628)
38. MW Pfaffl A Tichopad C Prgomet TP Neuvians 2004 Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations Biotechnol Lett 26 509 515 10.1023/B:BILE.0000019559.84305.47 1:CAS:528:DC%2BD2cXhvF2mtLk%3D 15127793 (Pubitemid 38448421)
39. P Reye R Sullivan H Scott DV Pow 2002 Distribution of two splice variants of the glutamate transporter GLT-1 in rat brain and pituitary Glia 38 246 255 10.1002/glia.10059 11968062 (Pubitemid 34900325)
40. RB Rothman MH Baumann 2003 Monoamine transporters and psychostimulant drugs Eur J Pharmacol 479 23 40 10.1016/j.ejphar.2003.08.054 1:CAS:528:DC%2BD3sXovVGntL4%3D 14612135 (Pubitemid 37377873)
41. JD Rothstein L Martin AI Levey M Dykes-Hoberg L Jin D Wu N Nash RW Kuncl 1994 Localization of neuronal and glial glutamate transporters Neuron 13 713 725 10.1016/0896-6273(94)90038-8 1:CAS:528:DyaK2MXhtVCktb0%3D 7917301 (Pubitemid 24300175)
42. Y Shigeri RP Seal K Shimamoto 2004 Molecular pharmacology of glutamate transporters, EAATs and VGLUTs Brain Res Brain Res Rev 45 250 265 10.1016/j.brainresrev.2004.04.004 1:CAS:528:DC%2BD2cXltVCgsr8%3D 15210307 (Pubitemid 38802874)
43. G Stumm J Schlegel T Schafer C Wurz HD Mennel JC Krieg H Vedder 1999 Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons Faseb J 13 1065 1072 1:CAS:528:DyaK1MXjsVOlu7w%3D 10336889
44. L Sun MT Shipley MS Lidow 2000 Expression of NR1, NR2A-D, and NR3 subunits of the NMDA receptor in the cerebral cortex and olfactory bulb of adult rat Synapse 35 212 221 10.1002/(SICI)1098-2396(20000301)35:3<212::AID- SYN6>3.0.CO;2-O 1:CAS:528:DC%2BD3cXot1Siuw%3D%3D 10657028 (Pubitemid 30056718)
45. ML Sveen GM Knudsen S Aznar 2004 No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures Neurosci Lett 362 6 9 10.1016/j.neulet.2004.01.051 1:CAS:528: DC%2BD2cXktVCksrg%3D 15147768 (Pubitemid 38638372)
46. AF Svenningsen WS Shan DR Colman L Pedraza 2003 Rapid method for culturing embryonic neuron-glial cell cocultures J Neurosci Res 72 565 573 10.1002/jnr.10610 1:CAS:528:DC%2BD3sXktFKns7Y%3D (Pubitemid 36578642)
47. G Tanda R Frau G Di Chiara 1995 Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex Psychopharmacology (Berl) 119 15 19 10.1007/BF02246048 1:CAS:528:DyaK2MXmtFChtLg%3D
48. U Ungerstedt 1971 Stereotaxic mapping of monoamine pathways in the rat brain Acta Physiol Scand Suppl 367 1 48 1:STN:280:DyaE38%2FovVChtA%3D%3D 4109331
49. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034
50. SR White P Duffy PW Kalivas 1994 Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo Neuroscience 62 41 50 10.1016/0306-4522(94)90313-1 1:CAS:528:DyaK2cXmsVKjsrc%3D 7816211 (Pubitemid 24287344)
51. X Zhuang C Gross L Santarelli V Compan AC Trillat R Hen 1999 Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors Neuropsychopharmacology 21 52S 60S 1:CAS:528:DyaK1MXltVOntLo%3D 10432489